Tag: Motley Fool

  • The Snowflake (NYSE:SNOW) share price is up 90% in two days

    asx brokers

    After a stunning start to life on the stock market on Wednesday, the Snowflake Inc (NYSE: SNOW) share price ran out of steam on Thursday and tumbled notably lower.

    The cloud-based data management company’s shares dropped over 10% to US$227.54.

    This appears to have been driven by a combination of a pullback in tech shares and profit taking from some investors.

    After all, despite the sizeable decline overnight, the Snowflake share price is still up almost 90% from its IPO price of US$120.00 per share.

    What is Snowflake?

    Snowflake is a leading cloud-based data platform provider which allows customers to consolidate data into a single source of truth to drive meaningful business insights, build data-driven applications, and share data.

    Demand for its offering has been growing rapidly in recent years. This led to it generating over US$500 million in annualised revenue during the first half of 2020, up over 130% on the prior corresponding period.

    Its IPO was well-supported, helping the company raise over US$3 billion to support its future growth.

    Among those taking part in the IPO was Warren Buffett’s Berkshire Hathaway. According to CNBC, it agreed to buy US$250 million worth of shares in the IPO and also a further 4 million shares via a secondary transaction.

    Though, it is understood that Mr Buffett wasn’t behind the investment. Rather, lieutenants Todd Combs and Ted Weschler are believed to have arranged the Snowflake bet.

    Buffett famously has a distaste for public offerings and hasn’t actually taken part in an IPO for almost 65 years. His last known IPO action came in 1956 when car giant Ford listed on the stock market.

    In 2019, Buffett told CNBC: “In 54 years, I don’t think Berkshire has ever bought a new issue. The idea of saying the best place in the world I could put my money is something where all the selling incentives are there, commissions are higher, the animal spirits are rising, that that’s going to better than 1,000 other things I could buy where there is no similar enthusiasm. … Just doesn’t make any sense.”

    Though, he may be very thankful that someone at Berkshire doesn’t necessarily agree with this view after Snowflake’s gains this week.

    These stocks could rocket in a Post-COVID world (FREE STOCK REPORT)

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.

    *Returns as of 6/8/2020

    More reading

    Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post The Snowflake (NYSE:SNOW) share price is up 90% in two days appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/3hKtP3o

  • Anglo (ASX:AAR) share price sinks on capital raising

    Hand holding gold nugget

    The Anglo Australian Resources NL (ASX: AAR) share price has fallen sharply today on news the company is capital raising. Anglo announced it was raising $14 million in a placement and share purchase plan (SPP). The Anglo share price is currently trading 5.41% lower at 18 cents.

    Anglo is an exploration company with interests in projects targeting gold and base metals, primarily copper and zinc. The company portfolio includes advanced and grass roots projects in Western Australia’s Eastern Goldfields, Kimberly and the Northern Territory.

    Capital raising

    Anglo’s share price fell today after the company said it had secured firm commitments to raise $11 million via a single tranche share placement. The placement comprises approximately 64.7 million shares issued at 17 cents per share to sophisticated and professional investors.

    In addition, Anglo is undertaking a SPP to raise up to $3 million. The SPP will be open to all eligible shareholders at the same issue price as the placement.

    The company will use existing cash reserves and proceeds of the capital raising to advance exploration, drilling and feasibility studies at the company’s Mandilla Gold Project. Mandilla is located 60km south of Kalgoorlie, Western Australia.

    Anglo managing director Marc Ducler said:

    The proceeds of this placement and SPP will provide an outstanding platform for Anglo to unlock the full value of the Mandilla Gold Project through an extensive exploration and resource definition drilling program, which will underpin the delivery of a maiden Mineral Resource Estimate during the December 2020 quarter as well as the commencement of technical and feasibility studies.

    What now for the Anglo share price?

    Funds used to complete the current drilling program at Mandilla as well as exploration, drilling and feasibility studies should realise positive gold finds for shareholders, according to the company.

    The Anglo share price has had a positive year buoyed by the record rise in the price of gold. Since the start of the year the Anglo share price is up 95%.

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of June 30th

    More reading

    Motley Fool contributor Daniel Ewing has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Anglo (ASX:AAR) share price sinks on capital raising appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/3ce28yP

  • Forget the uncertainty, here’s why you want to invest in ASX shares today

    Young man looking afraid representing scared BNPL shares investor

    You’ve likely heard the old investing platitude that share markets hate uncertainty.

    Just as you’ve probably heard the equally clichéd saying that share markets love easy money.

    Overused at they might be, both adages hold true. And they often compete to either send share prices higher or lower.

    But in the 30-odd years I’ve been following the markets, 13 of those professionally, I’ve never witnessed so much uncertainty battling it out with such a veritable flood of easy money.

    So many questions, so few answers

    On the uncertainty side, the global pandemic leads the charge.

    How many more lives will be lost? Will there or won’t there be a vaccine? What impact will a second wave have if it sweeps the northern nations during their upcoming winter? These are just a few of dozens of uncertainties surrounding the pandemic’s impact on global economies and share prices, and of course our very lives.

    But it’s far from just COVID-19 driving investor insecurities. Other uncertainties abound.

    Brexit is back on the front burner, with no clear exit agreements yet in place for the United Kingdom to part ways with the European Union.

    China is more of a wild card than ever. Both in its trade disputes with the United States and with its growing political rift with Australia. If you know how that’s going to turn out, drop us a line!

    Add to that the upcoming US presidential election and top it off with the growing odds of sovereign or major corporate defaults as debts pile up — no guarantees, mind you — and you can see why many people are hesitant to invest in shares.

    While that’s understandable, it’s also likely to be a costly mistake.

    Just how negative can interest rates get?

    Having touched on the uncertainties with the potential to drag share prices lower, let’s turn to the easy money side of the equation. The one with the potential to send share prices much higher.

    I won’t cover off all the central banks that have highly accommodative policies in place, because that list covers most all of them.

    Between them, global central banks have unleashed trillions of dollars in quantitative easing (QE). And they’ve driven interest rates down near zero. The Reserve Bank of Australia (RBA), with its bond buying and 0.25% official cash rate, is no exception. And neither record high levels of QE nor record low rates show any signs of abating in the foreseeable future.

    In fact, more central banks are inching towards negative interest rates, which have already been put into place by the European Central Bank (ECB) and Bank of Japan (BoJ).

    While RBA Governor, Philip Lowe, has effectively ruled out going negative, the same can’t be said across the ditch.

    Last month, the Reserve Bank of New Zealand (RBNZ) opted to keep New Zealand’s cash rate at its already record low 0.25%. However, the bank revealed that negative interest rates were part of “a package of additional monetary instruments” it’s actively preparing for.

    That statement was delivered before the full impact of the country’s lockdown on the economy was known.

    Yesterday, Statistics New Zealand shed some light on that impact. The report revealed that the Kiwi economy shrank 12.2% in the June 2020 quarter. That’s the biggest fall on record. And GDP per capita declined even more, down 12.6%.

    Now the RBNZ hasn’t made any new announcements on negative rates. But, according to the Australian Financial Review (AFR):

    New Zealand’s central bank has asked the big four Australia banks – which dominate the country’s banking system – to make sure they are technically and legally ready to handle a negative cash rate by the end of the year.

    Meanwhile, on the other side of the world, the Bank of England (BoE) is rushing down the same path. Also from the AFR: 

    The Bank of England has jumped on the bandwagon of negative interest rates, revealing late on Thursday (AEST) that its monetary policy committee is actively considering the technicalities of how to cut the benchmark rate below zero.

    Don’t fight the Fed

    Tom Lee is the Managing Partner and the Head of Research at Fundstrat Global Advisors and the former Chief Equity Strategist at global investment bank, JPMorgan.

    When balancing the uncertainties in one hand with the easy money environment in the other, he has a simple answer to share market investors, “Don’t fight the Fed.”

    As quoted by the AFR, Lee understands that investors are fearful faced with a once in a century pandemic and “the worst Depression in five lifetimes”.

    But he’s still optimistic, saying:

    I learned a long time ago that the stock market doesn’t care about my opinion and rather, my time is better spent trying to understand the message from the market. And we think the underlying message is one that remains constructive. That is, we think there are many factors that explain the extreme resilience of stocks in 2020.

    Chief among his reasons to be bullish, in his case on US shares, is the Fed’s continuing monetary support. Lee is also highly bullish on technology:

    Another key driver for US equities, in our view, is the world is facing a structural labour shortage. This is something we have written about since 2018 (the first year this took place) and if the world has population growth exceeding labour supply, this output gap/ worker shortage is solved by increasing reliance on capital-based labour, aka technology.

    While on the subject of technology…

    The dip in tech share prices could be a great buying opportunity

    Yesterday, overnight our time, the NASDAQ-100 (NASDAQ: NDX) dropped again, closing down 1.5%. That puts the tech-heavy index down 10.8% from its 2 September all-time highs.

    Tech shares on the ASX are heading the other way today, with the S&P/ASX All Technology Index (ASX: XTX) up 1.1% in early afternoon trading. Though it, too, is still down 8.5% from its own record highs of 25 August.

    If the world’s rapid pivot towards more technology-oriented working, shopping and socialising supported by a flood of easy central bank money indeed outweighs the great list of uncertainties, then both these indexes, and the shares that comprise them, should enjoy some more big gains in the months ahead.

    One way to gain exposure to the biggest US technology shares is the Betashares Nasdaq 100 ETF (ASX: NDQ). NDQ holds the largest non-financial 100 companies listed on the Nasdaq, including all the FAANG shares.

    NDQ’s share price is down 10.6% since 3 September. Year to date, the share price is up 18.4%.

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of June 30th

    More reading

    Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of BETANASDAQ ETF UNITS. The Motley Fool Australia has recommended BETANASDAQ ETF UNITS. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Forget the uncertainty, here’s why you want to invest in ASX shares today appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/3mwu2ei

  • Insiders have been buying NEXTDC (ASX:NXT) and this ASX share

    Investment stock market Entrepreneur Business Man discussing and analysis graph stock market trading,stock chart concept

    Every so often, I like to take a look to see which shares have experienced meaningful insider buying.

    This is because insider buying is often regarded as a bullish indicator, as few people know a company and its intrinsic value better than its own directors.

    A number of shares have reported meaningful insider buying this week. Here are a couple which have caught my eye:

    Betmakers Technology Group Ltd (ASX: BET)

    According to a change of director’s interest notice, one of this gambling technology company’s non-executive directors has been buying shares this month. The notice reveals that Matt Davey picked up a total of 212,766 shares through on-market trades between 14 September and 15 September. The director paid an average of 40 cents per share, which equates to a total consideration of $85,106.40.

    Mr Davey commented on the purchase. He said: “It’s always an exciting part of the journey at this stage of a business. We have done a fantastic job as a company to get to a point where we are ready to start scaling up both domestically and internationally and it’s great to be able to continue to demonstrate my support.”

    NEXTDC Ltd (ASX: NXT)

    Another change of director’s notice reveals that one of this data centre operator’s non-executive directors has been buying a large number of shares this week. According to the notice, Dr Eileen Doyle bought 13,800 shares through an on-market trade on 17 September. Dr Doyle paid an average of $11.59 per share, which equates to a total consideration of $159,942.

    These were the first shares that the director has bought after joining the company late last month. One broker that would support Dr Doyle’s decision is Goldman Sachs. Earlier this week it reiterated its buy rating and $13.20 price target on the company’s shares. The NEXTDC share price is changing hands for $11.82 this afternoon.

    These 3 stocks could be the next big movers in 2020

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.

    *Returns as of 6/8/2020

    More reading

    James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Cochlear Ltd. The Motley Fool Australia has recommended Cochlear Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Insiders have been buying NEXTDC (ASX:NXT) and this ASX share appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/2EcutsX

  • 3 exciting small cap ASX tech shares that could be the next big thing

    next big thing

    If you’re looking for exposure to the small side of the market, then you might want to consider the three small cap ASX tech shares listed below.

    I believe these three tech shares have the potential to grow materially in the future. This could make them great long term options for investors:

    Audinate Group Limited (ASX: AD8)

    Audinate is a digital audio-visual networking technologies provider that is best known for its innovative Dante audio over IP networking solution. This industry-leading product is used widely across the professional live sound, commercial installation, broadcast, and recording industries globally. While the company has been hit hard by the pandemic, it is in an excellent position to accelerate its growth once the crisis passes. Management notes that the number of Dante enabled products manufactured by its customers is a key measure of its technology proliferation. It is also traditionally a leading indicator of future revenue growth. Pleasingly, the company has achieved 31% growth in this metric and finished FY 2020 with 2,804 Dante-enabled products on the market. I believe this bodes well for its growth over the coming years.

    Mach7 Technologies Ltd (ASX: M7T)

    Another small cap tech share which I think has a lot of potential is Mach7. It is a growing medical imaging data management solutions provider. Mach7’s software creates a clear and complete view of the patient. This helps users with diagnoses, reduces care delivery delays and costs, and improves patient outcomes. In FY 2020 the company doubled its revenue to $18.9 million. The good news is that this is still only scratching at the surface of its sizeable market opportunity. Management estimates that its total addressable market is worth approximately US$2.75 billion per annum at present.

    Whispir (ASX: WSP)

    A final small cap tech share to look at is this software-as-a-service communications workflow platform provider. I think it is a great long term option for investors. Especially after a reasonably sharp pullback in its share price in recent weeks following the tech selloff. I believe Whispir has a very bright future ahead of it thanks to its industry-leading software platform. This platform allows users to deliver actionable two-way interactions at scale using automated multi-channel communication workflows. Management estimates that the Workflow Communications platform as a Service market could be worth US$8 billion per year by 2024.

    These 3 stocks could be the next big movers in 2020

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.

    *Returns as of 6/8/2020

    More reading

    James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and recommends MACH7 FPO and Whispir Ltd. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of AUDINATEGL FPO. The Motley Fool Australia has recommended AUDINATEGL FPO, MACH7 FPO, and Whispir Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post 3 exciting small cap ASX tech shares that could be the next big thing appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/2ZN5mo8

  • Lark (ASX:LRK) share price soars 25% on completion of capital raise

    Image of flying lark representing soaring Lark share price

    Lark Distilling Co Ltd (ASX: LRK) this morning announced the successful completion of its capital raise. This news has sent the Lark share price jumping 24.55% to $1.37, at the time of writing.

    This compares to the All Ordinaries Index (ASX: XAO) which is up just 1.05% for the day so far to 6,076.30 points.

    What does Lark do?

    Formerly known as Australian Whiskey Holdings Limited, Lark is involved in the Australian craft distilling industry. The company produces whiskey and liqueurs in Hobart, Tasmania.

    Completion of capital raise

    Lark updated the market today advising it had completed a capital raising of $8.85 million via an institutional placement. The offer was priced at $1.10 per share and the proceeds raised will be used to accelerate its growth strategy.

    The company has been busy ticking off its strategic roadmap and will leverage its balance sheet to broaden consumer appeal.

    The new shares will be allotted next week on 23 September.

    Management commentary

    Lark Managing Director, Geoff Bainbridge, was optimistic about Lark’s future. He said:

    The overwhelming support received for the Placement provides validation of the Lark growth strategy – brand and barrels – and will ensure that whisky under maturation will reach 1.5m Litres by the end of F22. The Placement is the next step into Lark’s journey to becoming a globally consumed, recognized and loved Tasmanian brand icon.

    Mr Bainbridge further added:

    It is the final milestone in the restructure of ‘Lark for growth’ plan, and it is a real coup for the Company to welcome such proven and highly regarded institutions to the Lark register.

    FY21 guidance

    Lark is forecasting to double its net sales in FY21 to $12 million. The company’s key drivers are expected to be from its e-commerce platform and direct mainland sales. In the first two months alone, e-commerce sales are more than all of FY20 e-commerce sales at a 6-fold increase. This has been underpinned by new, limited online releases selling out within hours/days.

    Specialty products Symphony No1 and Nant sales performance are tracking ahead of FY21 plans. To meet the rising demand, Lark will continue to increase whisky under maturation.

    In addition, the company will look to launch a portfolio strategy to address multiple occasions and price points. This will include the reboot of its Forty Spotted Gin product for Summer 2020.

    About the Lark share price

    The Lark share price has risen 63% since April this year and has slowly been trending upwards. At a market capitalisation of around $73 million, the Lark share price has an average volume of around 17,000 shares traded on any day. Today, that volume has increased to 301,000 shares being exchanged.

    Should you invest?

    I think that Lark has exciting growth prospects in the coming years. If the company is able to increase brand awareness and execute effective marketing strategies, sales should increase. This in-turn could drive the Lark share price up even further.

    I would recommended prospective investors adding Lark to their watchlist to monitor its future developments.

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of June 30th

    More reading

    Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Lark (ASX:LRK) share price soars 25% on completion of capital raise appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/33DL6Gz

  • Brokers name 3 ASX shares to buy right now

    finger pressing red button on keyboard labelled Buy

    Australia’s top brokers have been busy adjusting their estimates and recommendations again, leading to the release of a large number of broker notes this week.

    Three broker buy ratings that have caught my eye are summarised below. Here’s why brokers think these ASX shares are in the buy zone:

    Beach Energy Ltd (ASX: BPT)

    According to a note out of Citi, its analysts have upgraded this energy producer’s shares to a buy rating with a $1.94 price target. The broker believes that Beach Energy’s shares are attractively priced at the current level and offer a compelling risk/reward. It also likes the company due to its relative balance sheet strength in comparison to some of its peers. While I think Citi makes some great points, I would prefer to get exposure to energy through a more diversified miner.

    Challenger Ltd (ASX: CGF)

    Analysts at Credit Suisse have upgraded this annuities company’s sharers to an outperform rating with a $4.25 price target. The broker made move largely on valuation grounds after recent share price weakness. It notes that this has left Challenger’s shares trading at a large discount to its book value. And while it does acknowledge that the first half of FY 2021 could be difficult, it feels this is largely priced in now. I think it would be best to stay away from Challenger until there has been a notable improvement in its performance.

    Reject Shop Ltd (ASX: TRS)

    A note out of Morgans reveals that it has initiated coverage on this discount retailer’s shares with an add rating and $8.89 price target. According to the note, the broker believes the company’s turnaround program could deliver solid results in the coming years. It also sees plenty of room for the company to expand its store network meaningfully in the future. While I’m not a huge fan, I think Morgans makes some good points and Reject Shop could be worth a closer look.

    These stocks could rocket in a Post-COVID world (FREE STOCK REPORT)

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.

    *Returns as of 6/8/2020

    More reading

    Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Challenger Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Brokers name 3 ASX shares to buy right now appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/2ZPK8Wu

  • $10,000 invested in the Appen (ASX:APX) IPO is worth this much today

    Woman holding up wads of cash

    One of the most successful initial public offerings (IPOs) over the last few years came from Appen Ltd (ASX: APX).

    Appen is a leading provider of language technology data and services. It has team of over one million crowd-sourced experts around the globe providing or improving the data that is used for the development of machine learning and artificial intelligence products.

    When did Appen hit the ASX boards?

    Appen has been listed on the Australian share market for just over five and a half years.

    It listed in January 2015 after raising $15 million at 50 cents per share. This gave Appen a market capitalisation of $47.3 million.

    Management explained that the funds raised would help it “take advantage of, and grow with, the recent acceleration of devices and technology that interact with humans on human terms and advances in mobile communications and social media that are driving unified communication in any language and across languages.”

    It certainly achieved on this and has been growing at an extraordinary rate since 2015.

    For example, last month it released its half year results and revealed a 35% increase in underlying earnings before interest, tax, depreciation, and amortisation (EBITDA) to $62.5 million. That’s more than its entire market capitalisation upon listing.

    Looking ahead, the company expects a strong second half. It reaffirmed its guidance for underlying EBITDA in the range of $125 million to $130 million in FY 2020. This will be a 23.8% to 28.7% increase year on year.

    The good news is that more of the same is expected in the coming years.

    The company’s chairman, Chris Vonwiller, commented: “We are especially pleased with this result amidst the pandemic and the implementation of our growth initiatives. The strength of our business model, market exposure, competitive position and our consistent execution give us the confidence to push forward with our investments to solidify future growth.”

    What if you had invested in the Appen IPO?

    If you had invested $10,000 into Appen’s shares at its IPO, you would have picked up 20,000 shares at 50 cents each.

    At the time of writing, the company’s shares are changing hands for $31.83.

    This means your 20,000 shares would now have a market value of $636,600. Not bad for a $10,000 investment!

    These 3 stocks could be the next big movers in 2020

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.

    *Returns as of 6/8/2020

    More reading

    Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of Appen Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post $10,000 invested in the Appen (ASX:APX) IPO is worth this much today appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/3c7VzOp

  • ASX 200 down 0.1%: Tech shares push higher, AMP (ASX:AMP) sinks lower

    Worried young male investor watches financial charts on computer screen

    At lunch on Friday the S&P/ASX 200 Index (ASX: XJO) has given back its morning gains and is dropping lower. The benchmark index is currently down 0.1% to 5,879 points.

    Here’s what is happening on the market today:

    Tech shares push higher.

    The Australian tech sector is defying a sizeable decline on the Nasdaq index overnight and is pushing higher. At the time of writing, the S&P/ASX All Technology Index (ASX: XTX) is up 0.4%. The likes of Afterpay Ltd (ASX: APT) and Xero Limited (ASX: XRO) are on the rise today and helping to drive the technology index higher.

    AMP shares sink lower.

    The AMP Limited (ASX: AMP) share price is sinking notably lower today. But rather than another scandal or something operational, this decline can be attributed to the financial services company’s shares going ex-dividend for its 10 cents per share fully franked interim dividend. Eligible shareholders can look forward to being paid this dividend in just over two weeks on 1 October.

    Big four banks mostly lower.

    One area of the market acting as a drag on the market today is the banking sector. At lunch, three of the big four banks are in negative territory. The worst performer in the group is the Australia and New Zealand Banking GrpLtd (ASX: ANZ) share price with a 0.6% decline. The only bank pushing higher is National Australia Bank Ltd (ASX: NAB). At the time of writing, the NAB share price is up 0.3%.

    Best and worst ASX 200 performers.

    The best performer on the ASX 200 on Friday has been the Whitehaven Coal Ltd (ASX: WHC) share price with a gain of almost 4%. This follows a rise in spot coal prices overnight. The worst performer has been the AMP share price by some distance. Its shares are down 8.5% at lunch after trading ex-dividend this morning.

    These 3 stocks could be the next big movers in 2020

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.

    *Returns as of 6/8/2020

    More reading

    James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Xero. The Motley Fool Australia owns shares of AFTERPAY T FPO. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post ASX 200 down 0.1%: Tech shares push higher, AMP (ASX:AMP) sinks lower appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/33BohU4

  • Immutep (ASX:IMM) share price flying 20% on improving trials

    row of piggy banks with large one receiving injection representing rising Immutep share price

    The Immutep Ltd (ASX: IMM) share price is today flying as the company announced a number of results from its ongoing trials. The Immutep share price has gained a huge 20.45% today, rising to 26.5 cents at the time of writing.

    What Immutep does

    Immutep is a biotechnology company headquartered in Australia. Immutep focuses on personalised bio-therapeutic products for the treatment of cancer. Its main product is eftilagimod alpha (IMP321), a soluble fusion protein, which is in clinical development for the treatment of cancer. Immutep has two other clinical candidates (IMP701 and IMP731) that are fully licensed to major pharmaceutical partners, and a fourth candidate (IMP761) which is in pre-clinical development. 

    The company was originally built on CVac, a therapeutic cancer vaccine. In late 2014, the privately held French immunotherapy company Immutep SA was purchased by Prima Biotech. It is now dual listed with one listing on the ASX and another as Immutep ADS Representing 10 Ord Shs (NASDAQ: IMMP).

    INSIGHT-004 trial

    The Immutep share price is soaring higher today as it was announced that the company saw improving results from the INSIGHT-004 trial. The trial is evaluating the combination of Immutep’s lead product candidate, IMP321 with a human antibody (avelumab), in 12 patients with different solid tumours, primarily gastrointestinal.

    In positive news for the biotech, 41.7% of patients showed a partial response to the combination therapy of IMP321 and avelumab (previously 33%). Furthermore, there was encouraging levels of anti-tumour activity signals in a variety of the cancer indications. These are usually not typically sensitive to immune checkpoint inhibitor (ICI) therapy.

    On a final note, the combination of IMP321 and avelumab continues to be safe and well tolerated by patients.

    TACTI-002 Study

    The TACTI-002 study is being conducted in collaboration with Merck & Co., Inc. (NYSE: MRK). The study is evaluating the combination of IMP321 with Merck & Co’s Keytruda drug in patients with neck squamous cell carcinoma or lung cancer.

    The study has produced three complete responses, with two in neck squamous cell carcinoma and one in lung cancer. A complete response indicated the complete disappearance of all lesions.

    However it must be noted that, despite the improvement, the study has only produced a response in a total of 8 patients out of the 109 in the trial.

    What now for the Immutep share price?

    The improving results are great news for shareholders as the company seeks to return to its former highs. The Immutep share price has been on an impressive run since its lows in late March this year. The stock is up a huge 165% from its March low of 10 cents.

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of June 30th

    More reading

    Motley Fool contributor Daniel Ewing has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Immutep (ASX:IMM) share price flying 20% on improving trials appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/32DqYoL